Pharmacokinetics of aztreonam in infected patients
- 1 February 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 17 (2) , 215-219
- https://doi.org/10.1093/jac/17.2.215
Abstract
Pharmacokinetic parameters of aztreonam were determined in 22 patients with severe Gram-negative infections, treated with 0.5 or 1 g tid as an infusion of 30 min duration. Plasma concentrations were determined microbiologically. Most patients had various degrees of renal impairment and they showed a wide variety of age and body weight. The mean calculated volume of distribution was 17.31 or 260 ml/kg. The total plasma clearance correlated well with the creatinine clearance; the mean plasma clearance was 82 ml/min and the extrapolated extrarenal clearance was 9 ml/min. Actually measured half lives of aztreonam varied between 1 h 20 min, in a patient with normal renal function, and 9 h 40 min in a patient with severely impaired renal function. The results differ from predictions by other authors. Based on our results a dosage adjustment schedule for renal impairment is suggested.Keywords
This publication has 4 references indexed in Scilit:
- Pharmacokinetics of Aztreonam in Patients with Chronic Renal FailureClinical Pharmacokinetics, 1985
- Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunctionAntimicrobial Agents and Chemotherapy, 1983
- Review of Single- and Multiple-Dose Pharmacokinetics of the Monobactam, Aztreonam (SQ 26,776) in Healthy SubjectsChemotherapy, 1983
- Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjectsAntimicrobial Agents and Chemotherapy, 1982